Innovative Research Award
Xiaoyong Wang
Nanjing University
| Research Information |
| Researcher |
Xiaoyong Wang |
| Affiliation |
Nanjing University |
| Country |
China |
| Scopus ID |
57194713052 |
| Documents |
221 |
| Citations |
11,435 |
| h-index |
53 |
| Subject Area |
Anticancer drugs |
| Event |
World Skincare Innovation Awards |
The Innovative Research Award recognizes scholarly contributions associated with advanced biomedical and pharmaceutical investigations conducted by Xiaoyong Wang of Nanjing University. The researcher is widely associated with studies related to anticancer drug development, nanomedicine systems, and translational therapeutic technologies that contribute to modern pharmaceutical sciences and biomedical engineering research. The recognition presented within the framework of the World Skincare Innovation Awards highlights the interdisciplinary relevance of nanotechnology and therapeutic biomaterials in biomedical innovation and applied healthcare sciences
Abstract
Xiaoyong Wang has contributed to scientific research involving anticancer therapeutics, pharmaceutical nanotechnology, and biomedical material systems. The researcher’s publication profile demonstrates sustained academic productivity with significant citation influence in the fields of drug delivery, translational oncology, and therapeutic nanomedicine.[1] Research activities associated with advanced therapeutic formulations and interdisciplinary pharmaceutical technologies have established relevance in contemporary biomedical innovation. The recognition under the World Skincare Innovation Awards reflects the broader scientific impact of translational therapeutic research and emerging healthcare applications.
Keywords
- Anticancer drugs
- Nanomedicine
- Drug delivery systems
- Biomedical engineering
- Pharmaceutical sciences
- Therapeutic nanotechnology
- Cancer therapeutics
- Translational medicine
Introduction
Contemporary pharmaceutical and biomedical research increasingly emphasizes targeted therapeutic systems, biocompatible materials, and translational drug delivery technologies. Researchers engaged in anticancer drug development contribute to both clinical innovation and fundamental biomedical understanding.[3] Within this context, Xiaoyong Wang’s scholarly activities have focused on advanced therapeutic systems that integrate nanotechnology with pharmaceutical applications. The academic profile reflects interdisciplinary engagement across oncology-related biomedical sciences and therapeutic engineering domains.[4]
Research Profile
Xiaoyong Wang is affiliated with Nanjing University and has established a publication record indexed in Scopus with more than two hundred scholarly documents and a substantial citation history. The researcher’s h-index reflects sustained academic influence and continuing relevance within biomedical and pharmaceutical literature. Research interests are associated with therapeutic delivery systems, anticancer pharmaceutical technologies, and biomaterial-enabled medical applications.
- Advanced anticancer therapeutic systems
- Nanoparticle-mediated drug delivery
- Biomedical material engineering
- Translational pharmaceutical sciences
- Biocompatible therapeutic technologies
Research Contributions
Research contributions attributed to Xiaoyong Wang include investigations involving nanostructured therapeutic systems, drug transport mechanisms, and biomedical applications related to oncology-oriented pharmaceutical research.[3] Publications associated with therapeutic nanotechnology have explored methods intended to improve targeted delivery efficiency, biological compatibility, and controlled pharmacological activity.[6]
The interdisciplinary character of the research aligns pharmaceutical chemistry, nanomaterials, biomedical engineering, and translational medicine. Such integration is considered increasingly important in the development of modern precision therapeutics and biomedical innovation platforms.[4]
Publications
- Advanced nanomaterial systems for targeted anticancer applications and biomedical therapeutics.
- Biomedical nanotechnology approaches in translational cancer therapy and drug delivery engineering.
- Therapeutic nanoparticle systems for controlled pharmaceutical release and precision medicine.
Research Impact
The citation profile associated with Xiaoyong Wang indicates substantial scholarly visibility within biomedical and pharmaceutical research communities. Citation metrics and publication indexing suggest continuing relevance across multiple areas including oncology therapeutics, biomaterial engineering, and translational medicine. The integration of nanotechnology with therapeutic delivery systems has become an important direction in precision medicine and biomedical innovation, contributing to the broader significance of this research domain.
Award Suitability
The Innovative Research Award presented within the World Skincare Innovation Awards framework recognizes interdisciplinary scientific contributions relevant to biomedical innovation and translational therapeutic development. Xiaoyong Wang’s academic profile demonstrates sustained scholarly productivity, measurable citation impact, and involvement in advanced pharmaceutical technologies. The researcher’s work in anticancer therapeutic systems and biomedical nanotechnology aligns with broader scientific priorities emphasizing precision medicine, translational healthcare, and advanced material-enabled therapeutic applications.
Conclusion
Xiaoyong Wang’s research profile reflects significant academic engagement within the fields of anticancer therapeutics, nanomedicine, and pharmaceutical sciences. Publication metrics and citation performance indicate scholarly recognition within biomedical literature databases.[1] The Innovative Research Award acknowledges the broader scientific relevance of interdisciplinary therapeutic research and its potential contribution to future biomedical and healthcare innovations. Continued research activities within translational medicine and nanotechnology-driven therapeutic systems remain important areas of scientific development.
External Links
References
- Elsevier. (n.d.). Scopus author details: Xiaoyong Wang, Author ID 57194713052. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57194713052
- Wang, X. (2026). Optical heterostructure in a two-dimensional organic crystal. Nature Communications.
https://www.scopus.com/authid/detail.uri?authorId=57194713052
- Wang, X. (2026). Enhancing performance of CsSnBr3 light-emitting diodes via synergistic ion doping and in situ interfacial reaction. Angewandte Chemie International Edition.
https://www.scopus.com/authid/detail.uri?authorId=57194713052
- Wang, X. (2026). Full-Stokes polarization emission and detection of 2D chiral perovskites. Journal of Physical Chemistry Letters.
https://www.scopus.com/authid/detail.uri?authorId=57194713052
- Wang, X. (2026). Theoretical perspective on modulating bright-exciton fine-structure splitting in CsPbI3 nanocrystals via surface engineering. Physical Review B.
https://www.scopus.com/authid/detail.uri?authorId=57194713052